Mepolizumab for refractory eosinophilic fasciitis: a retrospective analysis from two tertiary care centres

Clin Exp Rheumatol. 2023 Aug;41(8):1721-1722. doi: 10.55563/clinexprheumatol/j7gexb. Epub 2023 May 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Asthmatic Agents*
  • Eosinophilia* / drug therapy
  • Fasciitis
  • Humans
  • Retrospective Studies
  • Tertiary Care Centers

Substances

  • mepolizumab
  • Anti-Asthmatic Agents

Supplementary concepts

  • Eosinophilic Fasciitis